Showing 1 - 10 of 31
Persistent link: https://www.econbiz.de/10011900636
Persistent link: https://www.econbiz.de/10012257465
Purpose – The purpose of this paper is to develop a comprehensive set of grocery store attributes that can be standardized and used in empirical research aiming at increasing retailers’ understanding of determinants of grocery store choice, and assessing how the relative importance of the...
Persistent link: https://www.econbiz.de/10014804919
Persistent link: https://www.econbiz.de/10013488742
Purpose Choosing how to invest one’s assets is one of the more important decisions consumers are faced with. However, determining the objective financial quality of complex investment products such as mutual funds is not an easy task for consumers. Against this background, this study aims to...
Persistent link: https://www.econbiz.de/10014723495
Purpose: The purpose of this paper is to verify the existence of a gender unbalance regarding choice of quantitatively oriented masters’ programs at a business school. The aim, further, is to analyze variables potentially affecting this unbalance: interest in quantitative matters, perceived...
Persistent link: https://www.econbiz.de/10012187050
Persistent link: https://www.econbiz.de/10012191352
Purpose – The purpose of this paper is to address reasons for consumer investment in socially responsible investment (SRI) profiled mutual funds. Specifically, the paper deals with the relative influence of financial return and social responsibility on the decision to invest in SRI profiled...
Persistent link: https://www.econbiz.de/10014759947
Purpose This paper aims to expand the emerging field of symbolic green consumer behavior (GCB) by investigating the impact of anticipated conspicuousness of the consumption situation on consumers’ choice of organic products. In addition, the paper also explores whether self-monitoring ability...
Persistent link: https://www.econbiz.de/10014897033
The ATHENA clinical trial enrolled 4,628 patients in 37 countries and evaluated the efficacy of dronedarone 400 mg twice daily versus placebo for the prevention of cardiovascular hospitalisation or death from any cause in patients with paroxysmal or persistent atrial fibrillation or atrial...
Persistent link: https://www.econbiz.de/10010993826